hotspot -WSS

hotspot

author：leisure time 2025-10-01 10:58:21 - browse：4872

he exterior of the U.S. Capitol building is seen at sunrise — Sarah Silbiger/Getty Images

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills.

The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today. The policies are not identical, but at least three PBM reforms have been passed by panels in both chambers:

One that would replace PBM fees that are tied to a percentage of drug prices with flat fees
Another that would require Medicare to create standard performance measures on which PBMs base pharmacy payments
A third that would require PBMs to report a host of information, including drug costs, savings, beneficiary out-of-pocket costs, payments to pharmacies, and the amount of business directed to PBM-owned pharmacies

The Energy & Commerce subcommittee also passed other bills that mirror legislation that Senate Finance also has passed. That includes legislation to ensure seniors pay no more for drugs than insurers, and a measure that lets insurers add less-expensive biosimilars to formularies mid-year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： UnitedHealth argues against case alleging wrongful AI care denials

explore

WSS

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Alabama IVF ruling threatens families facing fatal genetic disease

H5N1 virus can be tracked in retail milk, scientists say

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Questions and answers about ramping up H5N1 bird flu vaccine

ASCO eve: Let’s set the table for this year's meeting

entertainment

hotspot

Wikipedia

Medicare details structure of new drug price negotiation program

Eyeing GLP

ChatGPT in medicine: STAT answers readers' burning questions

Dario to buy mental health app maker Twill in cash and stock deal

Activists slam private health insurers over coverage restrictions

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Supreme Court strikes down use of affirmative action

Investigation reveals sickle cell patients pressured into sterilizations

leisure time

New documents shed light on MD Anderson Cancer Institute feud

FDA poised to publish guidelines for clinical trial diversity

PBM reform efforts get punted in Congress

FDA poised to publish guidelines for clinical trial diversity

Alabama hospital puts IVF treatments on hold

Fentanyl is making it harder to start addiction treatment

explore

knowledge

leisure time

leisure time